What is Bharat Parenterals Ltd (541096) share price return in the past 10 years?

Data is not available for this company

What is the share price of Bharat Parenterals Ltd (541096)?

Company share prices are keep on changing according to the market conditions. The current trading price of Bharat Parenterals Ltd (541096) on 04-Jun-2026 16:59:59 at 16:59 is 1380.00.

What is the P/E ratio of Bharat Parenterals?

The latest standalone P/E ratio of Bharat Parenterals as of 04-Jun-2026 is 59.37.

What is the P/B ratio of Bharat Parenterals Ltd (541096)?

The latest standalone P/B ratio of Bharat Parenterals Ltd (541096) as of 04-Jun-2026 is 2.36.

What is the 52-week high and low of Bharat Parenterals Ltd (541096)?

The 52-week high of Bharat Parenterals Ltd (541096) is Rs. 1667.20 and the 52-week low is Rs. 880.25.

Bharat Parenterals Ltd (541096) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Bharat Parenterals Ltd (541096)
Brand: Bharat Parenterals

Bharat Parenterals Ltd (541096)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 541096 NSE: Pharmaceuticals & Drugs | Small Cap | Bharat Parenterals Share Price

Bharat Parenterals Ltd (541096)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 541096 NSE: Pharmaceuticals & Drugs | Small Cap | Bharat Parenterals Share Price

Key Metrics

Valuation Multiples

Market Cap

₹951 Cr.

Current Price

₹1,380

52-Week Low / High

₹880 / 1,667

TTM EPS

₹23.2

TTM Sales

₹234 Cr.

Book Value per Share

₹583.8

P/E Ratio

59.37

Higher than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

2.36

Higher than its 5-year historical median

Price to Sales (P/S)

4.06

Higher than its 5-year historical median

EV/EBITDA

28.65

Higher than its 5-year historical median

Dividend Yield

0.10%

Profitability Efficiency

Return on Equity (ROE)

8.81%

In line with industry median

Return on Capital Employed (ROCE)

10.99%

In line with industry median

Return on Assets (ROA)

5.60%

Operating Profit Margin

11.4%

Net Profit Margin

8.7%

Gross Profit Margin

14.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

17.89%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

2.1%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

17.09%

Asset Quality

Promoter Holding

67.17%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹395 Cr.

Equity

₹6.9 Cr.

Face Value

₹10

All Time Low / High

₹116.25 / 1870.00

Bharat Parenterals stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Bharat Parenterals Ltd a good quality company?

Bharat Parenterals Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Bharat Parenterals Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Bharat Parenterals Ltd vs industry peers?

Bharat Parenterals Ltd revenue CAGR is 6.09%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Bharat Parenterals Ltd?

Promoters hold 67.17% of the Bharat Parenterals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Bharat Parenterals Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of 27.25% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	15.2%	12.1%	19.2%	39.8%	31.7%	19.8%	17.6%	16.6%	13%	11%	-
Value Creation Index ⓘ	0.1	-0.1	0.4	1.9	1.3	0.4	0.3	0.2	-0.1	-0.2	-
Growth Parameters ⓘ
Sales ⓘ	124	111	136	220	226	204	212	218	258	304	234
Sales YoY Gr.	-	-10.4%	22.6%	61.2%	3%	-10%	4.1%	2.8%	18.4%	17.9%	-
Adj EPS ⓘ	11.5	11.4	14	36.3	42.4	34.3	36.1	29.2	35.3	32.7	23.2
YoY Gr.	-	-1.6%	23.6%	158.8%	16.6%	-19.1%	5.4%	-19.1%	20.7%	-7.2%	-
BVPS (₹) ⓘ	99	112	129.7	169	214.9	250.5	287.7	329.9	367.1	561.3	583.8
Adj Net Profit ⓘ	6.6	6.5	8	20.8	24.3	19.6	20.9	16.9	20.5	22.6	16
Cash Flow from Ops. ⓘ	0	-1.9	6.3	20.3	14.5	21.9	-22.1	-11.6	-0.2	19.2	-
Debt/CF from Ops. ⓘ	0	-3.4	1.4	0.2	0.1	0.6	-0.7	-4	-513.4	3.4	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	10.5%	6.1%	12.8%	17.9%
Adj EPS ⓘ	12.3%	-5%	-3.2%	-7.2%
BVPSⓘ	21.3%	21.2%	25%	52.9%
Share Price	-	25.2%	56.4%	4.5%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	12.4	10.8	11.6	24.3	22.1	14.7	13.5	9.5	10.2	7.5	4.1
Op. Profit Mgn % ⓘ	8.3	6.3	9.7	13.8	13.4	12.3	13.8	10	12.8	11.4	9
Net Profit Mgn % ⓘ	5.3	5.9	5.9	9.5	10.7	9.6	9.8	7.7	8	7.4	6.8
Debt to Equity ⓘ	0.3	0.1	0.1	0.1	0	0.1	0.1	0.2	0.4	0.2	0
Working Cap Days ⓘ	220	229	223	169	200	189	199	276	367	362	200
Cash Conv. Cycle ⓘ	46	53	82	76	88	81	90	113	166	159	109

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	124	111	136	220	226	204	212	218	258	304
Operating Expenses ⓘ +	114	104	123	190	197	179	184	196	225	271
Manufacturing Costs	6	6	8	12	12	10	11	15	17	19
Material Costs	83	79	88	141	147	134	136	137	159	190
Employee Cost	9	11	12	14	14	14	15	17	20	21
Other Costs ⓘ	16	8	15	22	23	20	21	27	30	40
Operating Profit ⓘ	10	7	13	30	30	25	28	22	33	34
Operating Profit Margin (%)	8.0%	6.3%	9.6%	13.7%	13.2%	12.3%	13.4%	9.9%	12.8%	11.0%
Other Income ⓘ +	5	8	7	13	12	9	8	19	8	15
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	1	1	1	1	1	1	1	3	4	5
Depreciation ⓘ	4	6	6	6	6	6	7	6	6	7
Profit Before Tax ⓘ	9	8	14	36	35	27	28	32	31	36
Tax ⓘ	3	1	4	13	9	7	7	8	8	10
Profit After Tax	6	7	10	23	26	20	21	24	23	26
PAT Margin (%)	5.2%	6.6%	7.4%	10.3%	11.6%	9.9%	10.1%	11.2%	8.8%	8.7%
Adjusted EPS (₹)	11.3	12.9	17.6	39.4	45.9	35.3	36.9	42.1	38.8	38.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	1.80%	2.60%	2.60%

Valuation of Bharat Parenterals - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	57	64	74	97	123	144	166	191	214	387
Share Capital ⓘ	6	6	6	6	6	6	6	6	6	7
Reserves ⓘ	51	58	69	91	117	138	160	185	208	380
Debt +	19	4	7	3	1	10	13	43	80	62
Long Term Debt	7	4	2	1	1	9	10	7	4	2
Short Term Debt	13	0	5	2	0	1	3	36	76	60
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	39	36	26	32	43	26	23	48	52	63
Others Liabilities ⓘ	5	6	23	30	26	17	17	27	42	47
Total Liabilities ⓘ	120	110	131	161	192	196	218	308	387	558
Fixed Assets
Net Fixed Assets ⓘ +	35	31	34	34	32	43	40	35	38	45
Gross Block	62	36	44	50	54	71	73	74	82	85
Accumulated Depreciation	28	5	10	16	22	28	33	39	43	40
CWIP ⓘ	0	0	0	1	12	0	1	0	0	5
Investments ⓘ	1	1	1	3	2	42	16	38	49	168
Inventories	14	15	14	21	28	22	21	38	54	47
Trade Receivables	44	44	59	66	82	68	73	112	140	165
Cash Equivalents	13	2	4	12	10	2	5	7	5	28
Others Assets ⓘ	14	18	19	24	27	19	63	77	101	101
Total Assets ⓘ	120	110	131	161	192	196	218	308	387	558

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-2	6	20	14	22	-22	-12	-0	19
PBT ⓘ	8	14	36	35	27	28	32	31	36
Adjustment ⓘ	6	6	7	6	6	5	1	6	7
Changes in Working Capital ⓘ	-14	-11	-12	-17	-4	-49	-36	-28	-14
Tax Paid ⓘ	-2	-3	-10	-10	-7	-6	-9	-9	-10
Cash Flow From Investing Activity ⓘ +	-2	-8	-9	-13	-41	22	-14	-38	-90
Capex	-2	-8	-9	-15	1	-5	5	-10	-20
Net Investments	-0	-0	-1	1	-41	27	0	0	0
Others ⓘ	1	0	0	1	-0	-0	-19	-29	-70
Cash Flow From Financing Activity ⓘ +	-8	4	-4	-3	11	2	29	34	69
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	93
Net Proceeds from Borrowing ⓘ	0	0	0	0	10	1	-3	-3	-1
Interest Paid ⓘ	-1	-1	-1	-1	-0	-1	-2	-4	-5
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	-1
Others ⓘ	-7	5	-3	-2	1	2	33	41	-17
Net Cash Flow ⓘ	-11	2	7	-1	-8	2	3	-5	-1

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	12.1	12.21	14.59	26.38	23.92	15.16	13.76	13.65	11.18	8.81
ROCE (%)	15.21	12.09	19.15	39.83	31.68	19.8	17.59	16.62	12.97	10.99
Asset Turnover Ratio	1.11	1.03	1.15	1.5	1.28	1.22	1.16	0.96	0.74	0.65
PAT to CFO Conversion(x)	0	-0.29	0.6	0.87	0.54	1.1	-1.05	-0.5	-0	0.73
Working Capital Days
Receivable Days	142.50	135.60	135.80	103.50	118.80	115.40	107	134.20	177.80	182.20
Inventory Days	37.90	45	38.90	29.50	39.40	38.70	32.70	42.30	65.10	60.60
Payable Days	183.10	173.10	130.40	75.20	92.10	93.70	65.30	93.50	115.50	110.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Bharat Parenterals Ltd FAQs

The current trading price of Bharat Parenterals on 04-Jun-2026 16:59 is ₹1,380.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Bharat Parenterals stood at ₹951.1 Cr

The latest P/E ratio of Bharat Parenterals as of 03-Jun-2026 is 59.37.

The latest P/B ratio of Bharat Parenterals as of 03-Jun-2026 is 2.36.

The 52-week high of Bharat Parenterals is ₹1,667.2 and the 52-week low is ₹880.2.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bharat Parenterals is ₹234 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Bharat Parenterals Ltd is a average quality company.

The key valuation ratios of Bharat Parenterals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bharat Parenterals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Bharat Parenterals Ltd

No data to display

Bharat Parenterals Ltd (541096)

Bharat Parenterals Ltd (541096)

Bharat Parenterals stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Bharat Parenterals - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Bharat Parenterals Ltd FAQs

About Bharat Parenterals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Bharat Parenterals Ltd (541096)

Bharat Parenterals Ltd (541096)

Bharat Parenterals stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Bharat Parenterals - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Bharat Parenterals Ltd FAQs

What is the share price of Bharat Parenterals?

What is the market cap of Bharat Parenterals?

What is the P/E ratio of Bharat Parenterals?

What is the P/B ratio of Bharat Parenterals?

What is the 52-week high and low of Bharat Parenterals?

What is the TTM revenue of Bharat Parenterals?

Is Bharat Parenterals Ltd a good quality company?

Is Bharat Parenterals Ltd undervalued or overvalued?

Is Bharat Parenterals Ltd a good buy now?

About Bharat Parenterals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.